Format

Send to

Choose Destination
Beilstein J Nanotechnol. 2016 Nov 28;7:1861-1870. doi: 10.3762/bjnano.7.178. eCollection 2016.

Chitosan-based nanoparticles for improved anticancer efficacy and bioavailability of mifepristone.

Author information

1
College of Chemistry, Fuzhou University, Fuzhou 350108, China.
2
School of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350108, China.
3
College of Life Sciences, China Jiliang University, Hangzhou, Zhejiang, 310018, China.

Abstract

In addition to its well-known abortifacient effect, mifepristone (MIF) has been used as an anticancer drug for various cancers in many studies with an in-depth understanding of the mechanism of action. However, application of MIF is limited by its poor water solubility and low oral bioavailability. In this work, we developed a drug delivery system based on chitosan nanoparticles (CNs) to improve its bioavailability and anticancer activity. The MIF-loaded chitosan nanoparticles (MCNs) were prepared by convenient ionic gelation techniques between chitosan (Cs) and tripolyphosphate (TPP). The preparation conditions, including Cs concentration, TPP concentration, Cs/MIF mass ratio, and pH value of the TPP solution, were optimized to gain better encapsulation efficiency (EE) and drug loading capacity (DL). MCNs prepared with the optimum conditions resulted in spherical particles with an average size of 200 nm. FTIR and XRD spectra verified that MIF was successfully encapsulated in CNs. The EE and DL of MCNs determined by HPLC were 86.6% and 43.3%, respectively. The in vitro release kinetics demonstrated that MIF was released from CNs in a sustained-release manner. Compared with free MIF, MCNs demonstrated increased anticancer activity in several cancer cell lines. Pharmacokinetic studies in male rats that were orally administered MCNs showed a 3.2-fold increase in the area under the curve from 0 to 24 h compared with free MIF. These results demonstrated that MCNs could be developed as a potential delivery system for MIF to improve its anticancer activity and bioavailability.

KEYWORDS:

anticancer; chitosan; drug delivery; mifepristone; nanoparticles; pharmacokinetics; sustained release

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center